Visualizing infection spread: Dual-color fluorescent reporting of virus-host interactions

Biotechnology and Bioengineering

Volumn 111, Issue 6, 2014, Pages 1200-1209

  Swick, Adam ^a,b   Baltes, Ashley ^a,b   Yin, John ^a,b  

^a University of Wisconsin Madison   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Infection spread; Innate immune response; Interferon; Reporter virus; Vesicular stomatitis virus; Virus cell interactions

Indexed keywords

ANTIBIOTICS; CELLS; COLOR; CYTOLOGY; FLUORESCENCE; GENE EXPRESSION; GLYCOPROTEINS; IMMUNE SYSTEM; INTERFERONS; RECOMBINANT PROTEINS;

FLUORESCENT REPORTER; GREEN FLUORESCENT PROTEIN; INFECTION SPREAD; INNATE IMMUNE RESPONSE; INNATE IMMUNE SYSTEMS; MOLECULAR MECHANISM; RED FLUORESCENT PROTEINS; VESICULAR STOMATITIS VIRUS;

VIRUSES;

GREEN FLUORESCENT PROTEIN; IFIT 2 PROTEIN; INTERFERON REGULATORY FACTOR; RED FLUORESCENT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; IFIT2 PROTEIN, HUMAN; PHOTOPROTEIN; PROTEIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; DISEASE TRANSMISSION; HOST CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; RNA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS ACTIVATION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS INTERFERENCE; VIRUS REPLICATION; COLOR; FLUORESCENCE MICROSCOPY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; PHYSIOLOGY; PROCEDURES; STAINING; VESICULOVIRUS; VIROLOGY;

COLOR; HOST-PATHOGEN INTERACTIONS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; PROTEINS; RECOMBINANT PROTEINS; STAINING AND LABELING; VESICULOVIRUS; VIROLOGY;

EID: 84899520762     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25170     Document Type: Article

References (39)

1. Ahmed M, McKenzie MO, Puckett S, Hojnacki M, Poliquin L, Lyles DS. 2003. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J Virol 77:4646-4657.
2. Ahmed M, Cramer SD, Lyles DS. 2004. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses. Virology 330:34-49.
3. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 101:17264-17269.
4. Bluyssen HAR, Vlietstra RJ, Made AVANDER, Trapman J. 1994. The interferon-stimulated gene 54 K promoter contains two adjacent functional interferon-stimulated response elements of different strength, which act synergistically for maximal interferon-a inducibility. Eur J Biochem 220:395-402.
5. Carey BL, Ahmed M, Puckett S, Lyles DS. 2008. Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus. J Virol 82:12104-12115.
6. Chen S, Short JA, Young DF, Killip MJ, Schneider M, Goodbourn S, Randall RE. 2010. Heterocellular induction of interferon by negative-sense RNA viruses. Virology 407:247-255.
7. Dalton KP, Rose JK. 2001. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology 279:414-421. http://www.ncbi.nlm.nih.gov/pubmed/11162797
8. Das SC, Nayak D, Zhou Y, Pattnaik AK. 2006. Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells. J Virol 80:6368-6377.
9. Duca Ka, Lam V, Keren I, Endler EE, Letchworth GJ, Novella IS, Yin J. 2001. Quantifying viral propagation in vitro: Toward a method for characterization of complex phenotypes. Biotechnol Prog 17:1156-1165.
10. Duprex WP, McQuaid S, Hangartner L, Billeter MA, Rima BK. 1999. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol 73:9568-9575.
11. Duprex WP, McQuaid S, Roscic-Mrkic B, Cattaneo R, McCallister C, Rima BK. 2000. In vitro and in vivo infection of neural cells by a recombinant measles virus expressing enhanced green fluorescent protein. J Virol 74:7972-7979.
12. Elco CP, Guenther JM, Bryan RG, Sen GC. 2005. Analysis of genes induced by sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-κ B, and interferon but not toll-like receptor 3. J Virol 79:3920-3929.
13. Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, Diamond MS, Virgin HW, Sen GC. 2012. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog 8:e1002712.
14. Fuerst TR, Niles EG, Studier FW, Moss B. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83:8122-8126.
15. García-Sastre A, Biron CA. 2006. Type 1 interferons and the virus-host relationship: A lesson in détente. Science 312:879-882.
16. Gerlier D, Lyles DS. 2011. Interplay between innate immunity and negative-strand RNA viruses: Towards a rational model. Microbiol Mol Biol Rev 75:468-490.
17. Haseltine EL, Lam V, Yin J, Rawlings JB. 2008. Image-guided modeling of virus growth and spread. Bull Math Biol 70:1730-1748.
18. Hofacre A, Wodarz D, Komarova NL, Fan H. 2012. Early infection and spread of a conditionally replicating adenovirus under conditions of plaque formation. Virology 423:89-96.
19. Jöns A, Mettenleiter TC. 1997. Green fluorescent protein expressed by recombinant pseudorabies virus as an in vivo marker for viral replication. J Virol Methods 66:283-292.
20. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat Immunol 7:131-137.
21. Lam V, Duca KA, Yin J. 2005. Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity. Biotechnol Bioeng 90:793-804.
22. Lam V, Boehme KW, Compton T, Yin J. 2006. Spatial patterns of protein expression in focal infections of human cytomegalovirus. Biotechnol Bioeng 93:1-11.
23. Lawson ND, Stillman EA, Whitt MA, Rose JK. 1995. Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci USA 92:4477-4481.
24. Martínez-Sobrido L, Zúñiga EI, Rosario D, García-Sastre A, de la Torre JC. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 80:9192-9199.
25. Nguyen DN, Kim P, Martínez-Sobrido L, Beitzel B, García-Sastre A, Langer R, Anderson DG. 2009. A novel high-throughput cell-based method for integrated quantification of type I interferons and in vitro screening of immunostimulatory RNA drug delivery. Biotechnol Bioeng 103:664-675.
26. Payne AF, Binduga-Gajewska I, Kauffman EB, Kramer LD. 2006. Quantitation of flaviviruses by fluorescent focus assay. J Virol Methods 134:183-189.
27. Petersen JM, Her LS, Varvel V, Lund E, Dahlberg JE. 2000. The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol Cell Biol 20:8590-8601.
28. Rajani KR, Pettit Kneller EL, McKenzie MO, Horita DA, Chou JW, Lyles DS. 2012. Complexes of vesicular stomatitis virus matrix protein with host Rae1 and Nup98 involved in inhibition of host transcription. PLoS Pathog 8:e1002929.
29. Randall RE, Goodbourn S. 2008. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1-47.
30. Stojdl DF, Lichty BD, TenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J, Bell JC. 2003. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263-275.
31. Terenzi F, White C, Pal S, Williams BRG, Sen GC. 2007. Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J Virol 81:8656-8665.
32. Unterstab G, Ludwig S, Anton A, Planz O, Dauber B, Krappmann D, Heins G, Ehrhardt C, Wolff T. 2005. Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci USA 102:13640-13645.
33. Wacher C, Müller M, Hofer MJ, Getts DR, Zabaras R, Ousman SS, Terenzi F, Sen GC, King NJC, Campbell IL. 2007. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J Virol 81:860-871.
34. Wang X, Li M, Zheng H, Muster T, Palese PA, Beg AA, García-Sastre A. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74:11566-11573.
35. Whelan SP, Ball LA, Barr JN, Wertz GT. 1995. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci USA 92:8388-8392.
36. Wodarz D, Hofacre A, Lau JW, Sun Z, Fan H, Komarova NL. 2012. Complex spatial dynamics of oncolytic viruses in vitro: Mathematical and experimental approaches. PLoS Comput Biol 8:e1002547.
37. Wollmann G, Rogulin V, Simon I, Rose JK, van den Pol AN. 2010. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells. J Virol 84:1563-1573.
38. Yakimovich A, Gumpert H, Burckhardt CJ, Lütschg VA, Jurgeit A, Sbalzarini IF, Greber UF. 2012. Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model. J Virol 86:10123-10137.
39. Zhu Y, Yongky A, Yin J. 2009. Growth of an RNA virus in single cells reveals a broad fitness distribution. Virology 385:39-46.